Skip to main content
OpenTrials

Clinical trial condition

Atopic Dermatitis

Explore clinical trials studying Atopic Dermatitis. Study availability and eligibility vary by location and protocol.

858 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Atopic Dermatitis trial results

Completed

Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

NCT04345367

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Total Skin & Beauty Dermatology Center, PC Birmingham, Alabama, United States
  • Clinical Research Center Of Alabama Birmingham, Alabama, United States
  • Alliance Dermatology & MOHS Center, PC Phoenix, Arizona, United States
  • First OC Dermatology Fountain Valley, California, United States
View all 151 locations
View Trial Details
Completed

Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis

NCT04360187

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Dermatology Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Guangzhou First People's Hospital Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
View all 39 locations
View Trial Details
Completed

Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis

NCT02743871

Conditions
Atopic Dermatitis, Chronic Rhinosinusitis With Nasal Polyps, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • UC Davis Dermatology Sacramento, California, United States
  • UC Davis CTSC Clinical Research Center Sacramento, California, United States
  • UC Davis Health Sacramento, California, United States
  • New Haven Clinical Research Unit New Haven, Connecticut, United States
View all 20 locations
View Trial Details
Completed

Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.

NCT04250337

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Investigate MD Scottsdale, Arizona, United States
  • Orange County Research Institute Anaheim, California, United States
  • Bakersfield Dermatology and Skin Cancer Medical Group Bakersfield, California, United States
  • Wallace Medical Group, Inc. Beverly Hills, California, United States
View all 63 locations
View Trial Details
Completed

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis

NCT03796676

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States
  • Madera Family Medical Group Madera, California, United States
  • Allergy & Asthma Associates of Southern California dba Southern California Research Mission Viejo, California, United States
  • UC Davis Sacramento, California, United States
View all 136 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

NCT04018027

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +14 more
Locations
  • Cara Therapeutics Study Site Anniston, Alabama, United States
  • Cara Therapeutics Study Site Birmingham, Alabama, United States
  • Cara Therapeutics Study Site Scottsdale, Arizona, United States
  • Cara Therapeutics Study Site Bryant, Arkansas, United States
View all 40 locations
View Trial Details
Completed

Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis

NCT03107611

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Research Facility 6 Boynton Beach, Florida, United States
  • Research Facility 4 Coral Gables, Florida, United States
  • Research Facility 5 Miami, Florida, United States
  • Research Facility 10 Miami, Florida, United States
View all 27 locations
View Trial Details

Related conditions